NEWS & EVENTS
SEASON’S GREETINGS AND ALL THE BEST FOR 2024!
Vivosonic will be closed on December 22nd, 2023 until January 1st, 2024 inclusive, with limited service on December 27th and 28th.
Regular activity begins again on January 2nd, 2024.
VIVOSONIC AT BRITISH ACADEMY OF AUDIOLOGY – 19th ANNUAL CONFERENCE – November 12 – 13. 2023
Join us at the upcoming BAA Annual Conference!
Visit us at Booth A07 to see the unique advantages, easy-to-use features, and exceptional noise handling of the Integrity V500 System.
Learn more: https://vivosonic.com/our-technology/
EVALUATION OF HEARING IMPAIRMENT IN PATIENTS WITH DOWN SYNDROME
It is estimated that the prevalence of hearing loss in children with Down syndrome (DS) ranges from 38% to 82%. However, the diagnosis of hearing loss in DS is difficult, due to an impaired ability to cooperate for subjective tests. Thus, objective tests such as impedance audiometry, otoacoustic emissions, and auditory brainstem responses (ABRs) may be more appropriate. In this study objective methods without anesthesia were used to determine the amount, type, and prevalence of hearing loss in people with DS.
Read more: https://vivosonic.com/articles/
VIVOSONIC AT CAA CONFERENCE 2023 – Ottawa, Ontario, Canada
Come see us at the CAA Audiology Conference in October to learn about our latest features and developments. View a live demonstration! Vivosonic is proud to be part of the Infant Hearing Program in Ontario, which provides hearing screening for all newborns in hospital or community settings. We would be pleased to show you how easy it is to upgrade to an Integrity™ V500 System for your clinic or hospital.
For product information and sales related enquires: firstname.lastname@example.org
VIVOSONIC AT EHDI 2023
Join us at the EHDI 2023 Annual Meeting, March 5 – 7, in Cincinnati, OH. Visit our Vivosonic booth (#1) and see the latest version of our Integrity™ V500 System!
RELEASE OF INTEGRITY™ VERSION 8.11
We are pleased to inform you that we have just released software ver. 8.11 for Integrity™ G2 systems. This release includes many new exciting and convenient features, such as:
• Option to purchase as a 1-channel system (Ipsilateral recording) while allowing 2-channel patient setup and automatic channel switching — upgradeable to a 2-channel system (Ipsilateral and Contralateral recording) at any time without change of hardware
• Help (?) button on all screens for quick and easy access to instructional videos and user manuals
• New RETSPL option conforming to ISO standards in addition to currently available options
• Option to preview RETSPL values on System screen
Read more: https://bit.ly/integrity-latest-features
A study of Hyperbilirubinic and normal newborns showed that Hyperbilirubinemic newborns had decreased Medial Olivocochlear (MOC) reflex activity. This may be indicative of future problems in speech discrimination and effective hearing in noisy background. Additional long cohort studies are needed to evaluate the clinical importance of MOC reflex measurements in this group.
Obstructive sleep apnea syndrome (OSAS) is a respiratory syndrome that manifests during sleep. For the auditory system to be able to function normally, the inner ear and cochlear nerve require healthy oxygen support. The purpose of this study was to assess the hearing function of patients with OSAS and to reveal the relationship between polysomnographic parameters and hearing test results.
Vivosonic’s policy is to provide support for a period of 5 years from the date of withdrawal of a product from the market. It is now over 5 years since the sale of our last new G1 system and we currently have a limited inventory of parts available to service or repair these G1 systems. We are no longer providing software updates for these G1 systems and we no longer support Windows 7. As also previously communicated, support and parts are no longer available for the XP version.
Using the Vivosonic Integrity™ V500 System, the aim of this study was to investigate the VEMP* responses in conductive hearing loss using bone conduction stimulation. The response percentage of present VEMP waves by AC stimulation was 20% (4 ears). For BC stimulation, the rate increased to 75% (15 ears).
Early Hearing Detection and Intervention: Timely Diagnosis, Timely Management
Findlen, Ursula M.; Hounam, Gina M.; Alexy, Emily; Adunka, Oliver F.
Ear and Hearing, August 2018
This study examined how three clinical practice changes affected age at diagnosis: 1) Using Kalman-weighted signal averaging for ABR assessment, 2) Using a tone burst-prioritized protocol for assessment, and 3) Expediting the initial visit for infants.
Regarding the technology used for assessments, Kalman-weighted signal averaging ABRs may decrease the age at hearing determination for infants. Two factors decreased across the study time period: 1) The need for multiple tests to confirm diagnosis due to limited data obtained at initial evaluation and 2) difficulty testing due to limited infant sleep duration. Both of these factors can be improved by using Kalman-weighted signal averaging, which enhanced data collection efficiency when compared with conventional methods.
Click here to read full article.
Click image to view video excerpt: